注册 English

Synthesis of tetrazole containing 1,2,3-thiadiazole derivatives via U-4CR and their anti-TMV activity

Shou-Xin Wang ,  Zhen Fang ,  Zhi-Jin Fan ,  Dun Wang ,  Yue-Dong Li ,  Xiao-Tian Ji ,  Xue-Wen Hua ,  Yun Huang ,  Tatiana A. Kalinina ,  Vasiliy A. Bakulev ,  Yury Yu. Morzherin

downloadPDF
Citation:  Shou-Xin Wang, Zhen Fang, Zhi-Jin Fan, Dun Wang, Yue-Dong Li, Xiao-Tian Ji, Xue-Wen Hua, Yun Huang, Tatiana A. Kalinina, Vasiliy A. Bakulev, Yury Yu. Morzherin. Synthesis of tetrazole containing 1,2,3-thiadiazole derivatives via U-4CR and their anti-TMV activity[J]. Chinese Chemical Letters, 2013, 24(10): 889-892. shu

Synthesis of tetrazole containing 1,2,3-thiadiazole derivatives via U-4CR and their anti-TMV activity

    • 通讯作者: Zhi-Jin Fan,
    Yun Huang,
  • 基金项目:

    This study was funded in part by the NSF of Tianjin (No. 10JCZDJC17500) (No. 10JCZDJC17500)

    the National Key Project for Basic Research (No. 2010CB126105)  (No. 2010CB126105)

    Development Program (No. 2011BAE06B02)  (No. 2011BAE06B02)

    Technology (No. 201002250) (No. 201002250)

    Development Program (No. 11ZCGYNC00100) (No. 11ZCGYNC00100)

摘要: A series of novel tetrazole containing 1,2,3-thiadiazole derivatives were designed and synthesized via Ugi reaction. Their structures were confirmed by melting points, IR, 1H NMR, and HRMS (ESI). Preliminary bioassay indicated that most target compounds exhibited very good direct anti-TMV activity at 100 μg/mL, which was equal to or higher than that of ribavirin. Among them, compounds 4b, 4c and 4i also showed equivalent protection effect to ribavirin in vivo at 100 μg/mL.

English

  • 

    1. [1] R. Tripathy, A. Ghose, J. Singh, et al., 1,2,3-Thiadiazole substituted pyrazolones as potent KDR/VEGFR-2 kinase inhibitors, Bioorg. Med. Chem. Lett. 17 (2007) 1793-1798.[1] R. Tripathy, A. Ghose, J. Singh, et al., 1,2,3-Thiadiazole substituted pyrazolones as potent KDR/VEGFR-2 kinase inhibitors, Bioorg. Med. Chem. Lett. 17 (2007) 1793-1798.

    2. [2] W.L. Dong, Z.X. Liu, X.H. Liu, Z.M. Li, W.G. Zhao, Synthesis and antiviral activity of new acrylamide derivatives containing 1,2,3-thiadiazole as inhibitors of hepatitis B virus replication, Eur. J. Med. Chem. 45 (2010) 1919-1926.[2] W.L. Dong, Z.X. Liu, X.H. Liu, Z.M. Li, W.G. Zhao, Synthesis and antiviral activity of new acrylamide derivatives containing 1,2,3-thiadiazole as inhibitors of hepatitis B virus replication, Eur. J. Med. Chem. 45 (2010) 1919-1926.

    3. [3] Z.J. Fan, Z.K. Yang, H.K. Zhang, et al., Synthesis, crystal structure, and biological activity of 4-methyl-1,2,3-thiadiazole-containing 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles, J. Agric. Food Chem. 58 (2010) 2630-2636.[3] Z.J. Fan, Z.K. Yang, H.K. Zhang, et al., Synthesis, crystal structure, and biological activity of 4-methyl-1,2,3-thiadiazole-containing 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles, J. Agric. Food Chem. 58 (2010) 2630-2636.

    4. [4] X. Zuo, N. Mi, Z.J. Fan, et al., Synthesis of 4-methyl-1, 2,3-thiadiazole derivatives via Ugi reaction and their biological activities, J. Agric. Food Chem. 58 (2010) 2755-2762.[4] X. Zuo, N. Mi, Z.J. Fan, et al., Synthesis of 4-methyl-1, 2,3-thiadiazole derivatives via Ugi reaction and their biological activities, J. Agric. Food Chem. 58 (2010) 2755-2762.

    5. [5] V. Padmavathi, K. Mahesh, A.V. Nagendra Mohan, A. Padmaja, Synthesis and bioassay of oxazolyl/thiazolyl selenadiazoles, thiadiazoles and diazaphospholes, Chem. Pharm. Bull. 57 (2009) 561-566.[5] V. Padmavathi, K. Mahesh, A.V. Nagendra Mohan, A. Padmaja, Synthesis and bioassay of oxazolyl/thiazolyl selenadiazoles, thiadiazoles and diazaphospholes, Chem. Pharm. Bull. 57 (2009) 561-566.

    6. [6] H. Wang, Z.K. Yang, Z.J. Fan, et al., Synthesis and insecticidal activity of N-tertbutyl-N,N'-diacylhydrazines containing 1,2,3-thiadiazoles, J. Agric. Food Chem. 59 (2011) 628-634.[6] H. Wang, Z.K. Yang, Z.J. Fan, et al., Synthesis and insecticidal activity of N-tertbutyl-N,N'-diacylhydrazines containing 1,2,3-thiadiazoles, J. Agric. Food Chem. 59 (2011) 628-634.

    7. [7] M. Yasuda, M. Kusajima, M. Nakajima, et al., Thiadiazole carboxylic acid moiety of tiadinil, SV-03, induces systemic acquired resistance in tobacco without salicylic acid accumulation, J. Pestic. Sci. 31 (2006) 329-334.[7] M. Yasuda, M. Kusajima, M. Nakajima, et al., Thiadiazole carboxylic acid moiety of tiadinil, SV-03, induces systemic acquired resistance in tobacco without salicylic acid accumulation, J. Pestic. Sci. 31 (2006) 329-334.

    8. [8] Z.J. Fan, Y.W. Ai, J.Y. Chen, et al., Preparation of BTH standard and HPLC analysis of Bion 50%WG, J. Sichuan Normal Univ. (Nat. Sci.) 28 (2005) 608-610.[8] Z.J. Fan, Y.W. Ai, J.Y. Chen, et al., Preparation of BTH standard and HPLC analysis of Bion 50%WG, J. Sichuan Normal Univ. (Nat. Sci.) 28 (2005) 608-610.

    9. [9] Z.J. Fan, Z.G. Shi, H.K. Zhang, et al., Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance, J. Agric. Food Chem. 57 (2009) 4279-4286.[9] Z.J. Fan, Z.G. Shi, H.K. Zhang, et al., Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance, J. Agric. Food Chem. 57 (2009) 4279-4286.

    10. [10] Q.S. Du, W.P. Zhu, Z.J. Zhao, X.H. Qian, Y.F. Xu, Novel benzo-1,2,3-thiadiazole-7-carboxylate derivatives as plant activators and the development of their agricultural applications, J. Agric. Food Chem. 60 (2012) 346-353.[10] Q.S. Du, W.P. Zhu, Z.J. Zhao, X.H. Qian, Y.F. Xu, Novel benzo-1,2,3-thiadiazole-7-carboxylate derivatives as plant activators and the development of their agricultural applications, J. Agric. Food Chem. 60 (2012) 346-353.

    11. [11] W.T. Mao, H. Zhao, Z.J. Fan, et al.,A.B. Vasiliy, Synthesis and bioactivity of N-tertbutyl-N'-acyl-5-methyl-1,2,3-thiadiazole-4-carbohydrazides, Chin. Chem. Lett. 23 (2012) 1233-1236.[11] W.T. Mao, H. Zhao, Z.J. Fan, et al.,A.B. Vasiliy, Synthesis and bioactivity of N-tertbutyl-N'-acyl-5-methyl-1,2,3-thiadiazole-4-carbohydrazides, Chin. Chem. Lett. 23 (2012) 1233-1236.

    12. [12] S.D. Diwakar, S.S. Bhagwat, M.S. Shingare, C.H. Gill, Substituted 3-((Z)-2-(4-nitrophenyl)-2-(1H-tetrazol-5-yl) vinyl)-4H-chromen-4-ones as novel anti-MRSA agents: synthesis, SAR, and in-vitro assessment, Bioorg. Med. Chem. Lett. 18 (2008) 4678-4681.[12] S.D. Diwakar, S.S. Bhagwat, M.S. Shingare, C.H. Gill, Substituted 3-((Z)-2-(4-nitrophenyl)-2-(1H-tetrazol-5-yl) vinyl)-4H-chromen-4-ones as novel anti-MRSA agents: synthesis, SAR, and in-vitro assessment, Bioorg. Med. Chem. Lett. 18 (2008) 4678-4681.

    13. [13] K.S. Yeung, Z. Qiu, Z. Yang, et al., Inhibitors of HIV-1 attachment. Part 9. An assessment of oral prodrug approaches to improve the plasma exposure of a tetrazole-containing derivative, Bioorg. Med. Chem. Lett. 23 (2013) 209-212.[13] K.S. Yeung, Z. Qiu, Z. Yang, et al., Inhibitors of HIV-1 attachment. Part 9. An assessment of oral prodrug approaches to improve the plasma exposure of a tetrazole-containing derivative, Bioorg. Med. Chem. Lett. 23 (2013) 209-212.

    14. [14] Y.P. Luo, Q. Gong, Q. Chen, G.F. Yang, Synthesis and herbicidal activities of tetrazolinone derivatives containing oxime ether, Chin. J. Org. Chem. 28 (2008) 1561-1565.[14] Y.P. Luo, Q. Gong, Q. Chen, G.F. Yang, Synthesis and herbicidal activities of tetrazolinone derivatives containing oxime ether, Chin. J. Org. Chem. 28 (2008) 1561-1565.

    15. [15] M. Bertinaria, M.A. Shaikh, C. Buccellati, et al., Designing multitarget anti-inflammatory agents: chemical modulation of the lumiracoxib structure toward dual thromboxane antagonists-COX-2 inhibitors, ChemMedChem 7 (2012) 1647-1660.[15] M. Bertinaria, M.A. Shaikh, C. Buccellati, et al., Designing multitarget anti-inflammatory agents: chemical modulation of the lumiracoxib structure toward dual thromboxane antagonists-COX-2 inhibitors, ChemMedChem 7 (2012) 1647-1660.

    16. [16] R. Romagnoli, P.G. Baraldi, M.K. Salvador, et al., Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activity, J. Med. Chem. 55 (2012) 475-488.[16] R. Romagnoli, P.G. Baraldi, M.K. Salvador, et al., Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activity, J. Med. Chem. 55 (2012) 475-488.

    17. [17] C. Trécant, A. Dlubala, P. George, et al., Synthesis and biological evaluation of analogues of M6G, Eur. J. Med. Chem. 46 (2011) 4035-4041.[17] C. Trécant, A. Dlubala, P. George, et al., Synthesis and biological evaluation of analogues of M6G, Eur. J. Med. Chem. 46 (2011) 4035-4041.

    18. [18] A.S. Gundugola, K.L. Chandra, E.M. Perchellet, et al., Synthesis and antiproliferative evaluation of 5-oxo and 5-thio derivatives of 1,4-diaryl tetrazoles, Bioorg. Med. Chem. Lett. 20 (2010) 3920-3924.[18] A.S. Gundugola, K.L. Chandra, E.M. Perchellet, et al., Synthesis and antiproliferative evaluation of 5-oxo and 5-thio derivatives of 1,4-diaryl tetrazoles, Bioorg. Med. Chem. Lett. 20 (2010) 3920-3924.

    19. [19] S. Maeda, S. Komagawa, M. Uchiyama, K. Morokuma, Finding reaction pathways for multicomponent reactions: the passerini reaction is a four-component reaction, Angew. Chem. Int. Ed. 50 (2011) 644-649.[19] S. Maeda, S. Komagawa, M. Uchiyama, K. Morokuma, Finding reaction pathways for multicomponent reactions: the passerini reaction is a four-component reaction, Angew. Chem. Int. Ed. 50 (2011) 644-649.

    20. [20] W.H. Wang, X.M. Zou, X. Zhang, Y.Q. Fu, P. Xu, Solid-phase synthesis of PNA monomer by Ugi four-component condensation, Chin. Chem. Lett. 16 (2005) 585-588.[20] W.H. Wang, X.M. Zou, X. Zhang, Y.Q. Fu, P. Xu, Solid-phase synthesis of PNA monomer by Ugi four-component condensation, Chin. Chem. Lett. 16 (2005) 585-588.

    21. [21] S.S. Van Berkel, B.G.M. Bögels, M.A. Wijdeven, B. Westermann, F.P.J.T. Rutjes, Recent advances in asymmetric isocyanide-based multicomponent reactions, Eur. J. Org. Chem. (2012) 3543-3559.[21] S.S. Van Berkel, B.G.M. Bögels, M.A. Wijdeven, B. Westermann, F.P.J.T. Rutjes, Recent advances in asymmetric isocyanide-based multicomponent reactions, Eur. J. Org. Chem. (2012) 3543-3559.

    22. [22] C. Kalinski, M. Umkehrer, S. Gonnard, et al., A new and versatile Ugi/SNAr synthesis of fused 4,5-dihydrotetrazolo[1,5-a] quinoxalines, Tetrahedron Lett. 47 (2006) 2041-2044.[22] C. Kalinski, M. Umkehrer, S. Gonnard, et al., A new and versatile Ugi/SNAr synthesis of fused 4,5-dihydrotetrazolo[1,5-a] quinoxalines, Tetrahedron Lett. 47 (2006) 2041-2044.

    23. [23] T. Zhao, A. Boltjes, E. Herdtweck, A. Dömling, Tritylamine as an ammonia surrogate in the ugi tetrazole synthesis, Org. Lett. 15 (2013) 639-641.[23] T. Zhao, A. Boltjes, E. Herdtweck, A. Dömling, Tritylamine as an ammonia surrogate in the ugi tetrazole synthesis, Org. Lett. 15 (2013) 639-641.

    24. [24] F. Medda, C. Hulme, A facile and rapid route for the synthesis of novel 1,5-substituted tetrazole hydantoins and thiohydantoins via a TMSN3-Ugi/RNCX cyclization, Tetrahedron Lett. 53 (2012) 5593-5596.[24] F. Medda, C. Hulme, A facile and rapid route for the synthesis of novel 1,5-substituted tetrazole hydantoins and thiohydantoins via a TMSN3-Ugi/RNCX cyclization, Tetrahedron Lett. 53 (2012) 5593-5596.

    25. [25] D.K. Yuan, D.Q. Zhang, R.X. Li, D.Q. Wang, X.L. Yang, Synthesis and anti-TMV activity of novel N-(pyrimidin-5-yl)-N0-phenylureas, Chin. Chem. Lett. 22 (2011) 18-20.[25] D.K. Yuan, D.Q. Zhang, R.X. Li, D.Q. Wang, X.L. Yang, Synthesis and anti-TMV activity of novel N-(pyrimidin-5-yl)-N0-phenylureas, Chin. Chem. Lett. 22 (2011) 18-20.

    26. [26] Selected characteristic data for the target compounds. 4a: White solid; yield 59%; mp 75-76 ℃; 1H NMR (400 MHz, CDCl3): δ 0.93 (t, 3H, J = 7.6 Hz, propyl-CH3), 1.26-2.07 (m, 13H, propyl-CH2, 10cyclohexyl-H, NH), 2.45-2.62 (m, 2H, propyl-CH2), 2.65 (s, 3H, thiadiazole-CH3), 4.58-4.66 (m, 1H, cyclobutyl-CH), 5.76 (s, 1H, CH). HRMS: Calcd. for C14H23N7S (M+Na)+: 344.1628, Found: 344.1630; IR (KBr pellet press, cm 1): v3325, 2951, 2863, 1495, 1450, 1229, 1106, 1009, 809, 759. 4b: White solid; yield 47%; mp 96-97 ℃; 1H NMR (400 MHz, CDCl3):d 1.13 (t, 6H, J = 6.0 Hz, 2 isopropyl-CH3), 1.26-2.07 (m, 11H, 10 cyclohexyl-H, NH), 2.63 (s, 3H, thiadiazole-CH3), 2.64-2.71 (m, 1H, isopropyl-CH), 4.54-4.62 (m, 1H, cyclobutyl-CH), 5.83 (s, 1H, CH). HRMS: Calcd. for C14H23N7S (M+Na)+: 344.1628, Found: 344.1626; IR (KBr pellet press, cm 1): v 3276, 2934, 2857, 1501, 1451, 1241, 1126, 1009, 832. 4c: White solid; yield 51%; mp 96-97 ℃; 1H NMR (400 (M+H)+z, CDCl3): (0.43-0.54 (m, 4H, cyclopropyl-H), 1.33-2.05 (m, 11H, cyclohexyl-H, NH), 2.58 (s, 1H, cyclopropyl-CH), 2.66 (s, 3H, thiadiazole-CH3), 4.27-4.35 (m, 1H, cyclohexyl-CH), 5.58 (s, 1H, CH). HRMS: Calcd. for C14H21N7S (M+H)+: 320.1652, Found: 320.1657; IR (KBr pellet press, cm-1): n 3268, 2938, 2856, 1501, 1446, 1239, 1162, 1022, 801, 680. 4d: White solid; yield 53%; mp 88-89 ℃; 1H NMR (400 (M+H)+z, CDCl3): δ 1.31-2.17 (m, 17H, 5 cyclopropyl-H, 10 cyclohexyl-H, CH2), 2.63 (s, 3H, thiadiazole-CH3), 3.13 (s, 1H, NH), 4.53-4.60 (m, 1H, cyclohexyl-H), 5.72 (s, 1H, CH). HRMS: Calcd. for C15H23N7S (M+Na)+: 356.1628, Found: 356.1623; IR (KBr pellet press, cm 1): v3265, 2941, 2856, 1501, 1466, 1241, 1151, 1009, 810. 4e: White solid; yield 57%; mp 119-120 ℃; 1H NMR (400 (M+H)+z, CDCl3): δ 1.10 (s, 9H, 3t-butyl-CH3), 1.26-2.07 (m, 11H, 10 cyclohexyl-H, NH), 2.57 (s, 3H, thiadiazole-CH3), 4.37-4.45 (m, 1H, cyclohexyl-CH), 5.84 (s, 1H, CH). HRMS: Calcd. for C15H25N7S (M+Na)+: 358.1784, Found: 358.1787; IR (KBr pellet press, cm-1): v3327, 2938, 2865, 1453, 1231, 1103, 1076, 861, 741. 4f: White solid; yield 60%; mp 87-88 ℃; 1H NMR (400 MHz, CDCl3):d 1.26-2.17 (m, 17H, 6 cyclobutyl-H, 10 cyclohexyl-H, NH), 2.63 (s, 3H, thiadiazole-CH3), 3.11-3.14 (m, 1H, cyclobutyl-CH), 4.49-4.56 (m, 1H, cyclohexyl-CH), 5.70 (s, 1H, CH). HRMS: Calcd. for C15H23N7S (M+Na)+: 356.1628, Found: 356.1629; IR (KBr pellet press, cm 1): v3264, 2941, 2856, 1501, 1451, 1241, 1150, 1105, 1009, 809, 759. 4g: White solid; yield 58%; mp 122-123 ℃; 1H NMR (400 MHz, CDCl3):d 1.32-2.00 (m, 19H, 8 cyclopentyl-H, 10 cyclohexyl-H, NH), 2.63 (s, 3H, thiadiazole-CH3), 2.89-2.95 (m, 1H, cyclopentyl-CH), 4.53-4.60 (m, 1H, cyclohexyl-CH), 5.72 (s, 1H, CH). HRMS: Calcd. for C16H25N7S (M H) : 346.1819, Found: 346.1814; IR (KBr pellet press, cm 1): v3271, 2938, 2857, 1499, 1449, 1236, 1087, 1005, 844, 732. 4h: White solid; yield 47%; mp 98-99 ℃; 1H NMR (400 (M+H)+z, CDCl3):d 1.11-2.05 (m, 21H, 20 cyclohexyl-H, NH), 2.30-2.32 (m, 1H, cyclohexyl-CH), 2.62 (s, 3H, thiadiazole-CH3), 4.56-4.64 (m, 1H, cyclohexyl-H), 5.90 (s, 1H, CH). HRMS: Calcd. for C17H27N7S (M H) : 360.1976, Found: 360.1973; IR (KBr pellet press, cm 1): v3286, 2927, 2850, 1451, 1236, 1106, 1012, 824, 686. 4i: White solid; yield 55%; mp 96-97 ℃; 1H NMR(400 (M+H)+z, CDCl3):d 1.26-1.99 (m, 10H, cyclohexyl-H), 2.65 (s, 3H, thiadiazole-CH3), 4.35-4.41 (m, 1H, cyclohexyl-H), 4.72 (d, 1H, J = 8.0 Hz, NH), 6.32 (d, 1H, J = 8.0 Hz, CH), 6.66-7.09 (m, 4H, Ph-H). HRMS: Calcd. for C17H20FN7S (M+H)+: 374.1558, Found: 374.1555; IR (KBr pellet press, cm 1): v3401, 2936, 2860, 1620, 1527, 1453, 1251, 1191, 1057, 738. 4j: Pale yellow solid; yield 50%; mp 115-116 ℃; 1H NMR (400 (M+H)+z, CDCl3):d 1.26-1.99 (m, 10H, 10 cyclohexyl-H), 2.66 (s, 3H, thiadiazole-CH3), 4.27-4.33 (m, 1H, cyclohexyl-CH), 5.09 (d, 1H, J = 6.0 Hz, NH), 6.23 (d, 1H, J = 7.6 Hz, CH), 6.56 (d, 1H, J = 8.4 Hz, Ph-H), 6.70 (s, 1H, Ph-H), 6.85 (d, 1H, J = 8.4 Hz, Ph-H), 7.12 (t, 1H, J = 8.0 Hz, Ph-H). HRMS: Calcd. for C17H20ClN7S (M H) : 388.1117, Found: 388.1112; IR (KBr pellet press, cm 1): v3410, 2937, 2861, 1598, 1484, 1446, 1272, 1158, 1012, 845, 759. 4k: Pale yellow solid; yield 46%; mp 152-153 ℃; 1H NMR (400 MHz, CDCl3):d 1.26-2.01 (m, 10H, 10 cyclohexyl-H), 2.66 (s, 3H, thiadiazole-CH3), 4.25-4.32 (m, 1H, cyclohexyl-CH), 4.80 (d, 1H, J = 7.2 Hz, NH), 6.20 (d, 1H, J = 7.2 Hz, CH), 6.63 (d, 2H, J = 8.8 Hz, Ph-H), 7.18 (d, 2H, J = 8.4 Hz, Ph-H). HRMS: Calcd. for C17H20ClN7S (M H) : 388.1117, Found: 388.1119; IR (KBr pellet press, cm 1): v3285, 2944, 2856, 1598, 1497, 1442, 1296, 1245, 1103, 1011, 837. 4l: White solid; yield 45%; mp 149-150 (oC; 1H NMR (400 MHz, CDCl3):d 1.17 (t, 3H, J = 7.6 Hz, ethyl-CH3), 1.24-2.00 (m, 10H, 10 cyclohexyl-H), 2.50 (q, 2H, J = 15.2 Hz, ethyl-CH2), 2.63 (s, 3H, thiadiazole-CH3), 4.27-4.34 (m, 1H, cyclohexyl-CH), 4.41 (d, 1H, J = 5.2 Hz, NH), 6.18 (d, 1H, J = 8.0 Hz, CH), 6.63 (d, 2H, J = 8.4 Hz, Ph-H), 7.05 (d, 2H,, J = 8.4 Hz, Ph-H). HRMS: Calcd. for C19H25N7S (M+Na)+: 406.1784, Found: 406.1783; IR (KBr pellet press, cm 1): v3419, 2935, 2862, 1616, 1523, 1446, 1281, 1102, 818, 756. 4m: White solid; yield 48%; mp 143-144 (C; 1H NMR (400 (M+H)+z, CDCl3): δ 1.27-2.00 (m, 10H, cyclohexyl-H), 2.15 (s, 3H, Ph-CH3), 2.65 (s, 3H, thiadiazole-CH3), 4.29-4.34 (m, 1H, cyclohexyl-CH), 4.75 (d, 1H, J = 7.6 Hz, NH), 6.19 (d, 1H, J = 7.6 Hz, CH), 6.36-6.41 (m, 2H, PhH), 7.00 (t, 1H, J = 8.4 Hz, PhH). HRMS: Calcd. for C18H22FN7S (M-H)-: 386.1569, Found: 386.1571; IR (KBr pellet press, cm-1): v3285, 2927, 2849, 1496, 1450, 1236, 1133, 1012, 824, 686.[26] Selected characteristic data for the target compounds. 4a: White solid; yield 59%; mp 75-76 ℃; 1H NMR (400 MHz, CDCl3): δ 0.93 (t, 3H, J = 7.6 Hz, propyl-CH3), 1.26-2.07 (m, 13H, propyl-CH2, 10cyclohexyl-H, NH), 2.45-2.62 (m, 2H, propyl-CH2), 2.65 (s, 3H, thiadiazole-CH3), 4.58-4.66 (m, 1H, cyclobutyl-CH), 5.76 (s, 1H, CH). HRMS: Calcd. for C14H23N7S (M+Na)+: 344.1628, Found: 344.1630; IR (KBr pellet press, cm 1): v3325, 2951, 2863, 1495, 1450, 1229, 1106, 1009, 809, 759. 4b: White solid; yield 47%; mp 96-97 ℃; 1H NMR (400 MHz, CDCl3):d 1.13 (t, 6H, J = 6.0 Hz, 2 isopropyl-CH3), 1.26-2.07 (m, 11H, 10 cyclohexyl-H, NH), 2.63 (s, 3H, thiadiazole-CH3), 2.64-2.71 (m, 1H, isopropyl-CH), 4.54-4.62 (m, 1H, cyclobutyl-CH), 5.83 (s, 1H, CH). HRMS: Calcd. for C14H23N7S (M+Na)+: 344.1628, Found: 344.1626; IR (KBr pellet press, cm 1): v 3276, 2934, 2857, 1501, 1451, 1241, 1126, 1009, 832. 4c: White solid; yield 51%; mp 96-97 ℃; 1H NMR (400 (M+H)+z, CDCl3): (0.43-0.54 (m, 4H, cyclopropyl-H), 1.33-2.05 (m, 11H, cyclohexyl-H, NH), 2.58 (s, 1H, cyclopropyl-CH), 2.66 (s, 3H, thiadiazole-CH3), 4.27-4.35 (m, 1H, cyclohexyl-CH), 5.58 (s, 1H, CH). HRMS: Calcd. for C14H21N7S (M+H)+: 320.1652, Found: 320.1657; IR (KBr pellet press, cm-1): n 3268, 2938, 2856, 1501, 1446, 1239, 1162, 1022, 801, 680. 4d: White solid; yield 53%; mp 88-89 ℃; 1H NMR (400 (M+H)+z, CDCl3): δ 1.31-2.17 (m, 17H, 5 cyclopropyl-H, 10 cyclohexyl-H, CH2), 2.63 (s, 3H, thiadiazole-CH3), 3.13 (s, 1H, NH), 4.53-4.60 (m, 1H, cyclohexyl-H), 5.72 (s, 1H, CH). HRMS: Calcd. for C15H23N7S (M+Na)+: 356.1628, Found: 356.1623; IR (KBr pellet press, cm 1): v3265, 2941, 2856, 1501, 1466, 1241, 1151, 1009, 810. 4e: White solid; yield 57%; mp 119-120 ℃; 1H NMR (400 (M+H)+z, CDCl3): δ 1.10 (s, 9H, 3t-butyl-CH3), 1.26-2.07 (m, 11H, 10 cyclohexyl-H, NH), 2.57 (s, 3H, thiadiazole-CH3), 4.37-4.45 (m, 1H, cyclohexyl-CH), 5.84 (s, 1H, CH). HRMS: Calcd. for C15H25N7S (M+Na)+: 358.1784, Found: 358.1787; IR (KBr pellet press, cm-1): v3327, 2938, 2865, 1453, 1231, 1103, 1076, 861, 741. 4f: White solid; yield 60%; mp 87-88 ℃; 1H NMR (400 MHz, CDCl3):d 1.26-2.17 (m, 17H, 6 cyclobutyl-H, 10 cyclohexyl-H, NH), 2.63 (s, 3H, thiadiazole-CH3), 3.11-3.14 (m, 1H, cyclobutyl-CH), 4.49-4.56 (m, 1H, cyclohexyl-CH), 5.70 (s, 1H, CH). HRMS: Calcd. for C15H23N7S (M+Na)+: 356.1628, Found: 356.1629; IR (KBr pellet press, cm 1): v3264, 2941, 2856, 1501, 1451, 1241, 1150, 1105, 1009, 809, 759. 4g: White solid; yield 58%; mp 122-123 ℃; 1H NMR (400 MHz, CDCl3):d 1.32-2.00 (m, 19H, 8 cyclopentyl-H, 10 cyclohexyl-H, NH), 2.63 (s, 3H, thiadiazole-CH3), 2.89-2.95 (m, 1H, cyclopentyl-CH), 4.53-4.60 (m, 1H, cyclohexyl-CH), 5.72 (s, 1H, CH). HRMS: Calcd. for C16H25N7S (M H) : 346.1819, Found: 346.1814; IR (KBr pellet press, cm 1): v3271, 2938, 2857, 1499, 1449, 1236, 1087, 1005, 844, 732. 4h: White solid; yield 47%; mp 98-99 ℃; 1H NMR (400 (M+H)+z, CDCl3):d 1.11-2.05 (m, 21H, 20 cyclohexyl-H, NH), 2.30-2.32 (m, 1H, cyclohexyl-CH), 2.62 (s, 3H, thiadiazole-CH3), 4.56-4.64 (m, 1H, cyclohexyl-H), 5.90 (s, 1H, CH). HRMS: Calcd. for C17H27N7S (M H) : 360.1976, Found: 360.1973; IR (KBr pellet press, cm 1): v3286, 2927, 2850, 1451, 1236, 1106, 1012, 824, 686. 4i: White solid; yield 55%; mp 96-97 ℃; 1H NMR(400 (M+H)+z, CDCl3):d 1.26-1.99 (m, 10H, cyclohexyl-H), 2.65 (s, 3H, thiadiazole-CH3), 4.35-4.41 (m, 1H, cyclohexyl-H), 4.72 (d, 1H, J = 8.0 Hz, NH), 6.32 (d, 1H, J = 8.0 Hz, CH), 6.66-7.09 (m, 4H, Ph-H). HRMS: Calcd. for C17H20FN7S (M+H)+: 374.1558, Found: 374.1555; IR (KBr pellet press, cm 1): v3401, 2936, 2860, 1620, 1527, 1453, 1251, 1191, 1057, 738. 4j: Pale yellow solid; yield 50%; mp 115-116 ℃; 1H NMR (400 (M+H)+z, CDCl3):d 1.26-1.99 (m, 10H, 10 cyclohexyl-H), 2.66 (s, 3H, thiadiazole-CH3), 4.27-4.33 (m, 1H, cyclohexyl-CH), 5.09 (d, 1H, J = 6.0 Hz, NH), 6.23 (d, 1H, J = 7.6 Hz, CH), 6.56 (d, 1H, J = 8.4 Hz, Ph-H), 6.70 (s, 1H, Ph-H), 6.85 (d, 1H, J = 8.4 Hz, Ph-H), 7.12 (t, 1H, J = 8.0 Hz, Ph-H). HRMS: Calcd. for C17H20ClN7S (M H) : 388.1117, Found: 388.1112; IR (KBr pellet press, cm 1): v3410, 2937, 2861, 1598, 1484, 1446, 1272, 1158, 1012, 845, 759. 4k: Pale yellow solid; yield 46%; mp 152-153 ℃; 1H NMR (400 MHz, CDCl3):d 1.26-2.01 (m, 10H, 10 cyclohexyl-H), 2.66 (s, 3H, thiadiazole-CH3), 4.25-4.32 (m, 1H, cyclohexyl-CH), 4.80 (d, 1H, J = 7.2 Hz, NH), 6.20 (d, 1H, J = 7.2 Hz, CH), 6.63 (d, 2H, J = 8.8 Hz, Ph-H), 7.18 (d, 2H, J = 8.4 Hz, Ph-H). HRMS: Calcd. for C17H20ClN7S (M H) : 388.1117, Found: 388.1119; IR (KBr pellet press, cm 1): v3285, 2944, 2856, 1598, 1497, 1442, 1296, 1245, 1103, 1011, 837. 4l: White solid; yield 45%; mp 149-150 (oC; 1H NMR (400 MHz, CDCl3):d 1.17 (t, 3H, J = 7.6 Hz, ethyl-CH3), 1.24-2.00 (m, 10H, 10 cyclohexyl-H), 2.50 (q, 2H, J = 15.2 Hz, ethyl-CH2), 2.63 (s, 3H, thiadiazole-CH3), 4.27-4.34 (m, 1H, cyclohexyl-CH), 4.41 (d, 1H, J = 5.2 Hz, NH), 6.18 (d, 1H, J = 8.0 Hz, CH), 6.63 (d, 2H, J = 8.4 Hz, Ph-H), 7.05 (d, 2H,, J = 8.4 Hz, Ph-H). HRMS: Calcd. for C19H25N7S (M+Na)+: 406.1784, Found: 406.1783; IR (KBr pellet press, cm 1): v3419, 2935, 2862, 1616, 1523, 1446, 1281, 1102, 818, 756. 4m: White solid; yield 48%; mp 143-144 (C; 1H NMR (400 (M+H)+z, CDCl3): δ 1.27-2.00 (m, 10H, cyclohexyl-H), 2.15 (s, 3H, Ph-CH3), 2.65 (s, 3H, thiadiazole-CH3), 4.29-4.34 (m, 1H, cyclohexyl-CH), 4.75 (d, 1H, J = 7.6 Hz, NH), 6.19 (d, 1H, J = 7.6 Hz, CH), 6.36-6.41 (m, 2H, PhH), 7.00 (t, 1H, J = 8.4 Hz, PhH). HRMS: Calcd. for C18H22FN7S (M-H)-: 386.1569, Found: 386.1571; IR (KBr pellet press, cm-1): v3285, 2927, 2849, 1496, 1450, 1236, 1133, 1012, 824, 686.

  • 加载中
WeChat 扫一扫看文章
计量
  • PDF下载量:  0
  • 文章访问数:  2114
  • HTML全文浏览量:  46
文章相关
  • 收稿日期:  2013-04-07
  • 网络出版日期:  2013-05-07
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

/

返回文章

All Rights Reserved by the Chinese Chemical Society   中国化学会 版权所有 京ICP备05002797号

本系统由北京仁和汇智信息技术有限公司开发    技术支持: info@rhhz.net